-
1
-
-
0033631547
-
Impact of end-stage renal disease and dialysis on glycemic control
-
R.H. Mak Impact of end-stage renal disease and dialysis on glycemic control Semin Dial 13 1 2000 4 8
-
(2000)
Semin Dial
, vol.13
, Issue.1
, pp. 4-8
-
-
Mak, R.H.1
-
2
-
-
0021920713
-
Role of parathyroid hormone in the glucose intolerance of chronic renal failure
-
M. Akmal, S.G. Massry, D.A. Goldstein, P. Fanti, A. Weisz, and R.A. DeFronzo Role of parathyroid hormone in the glucose intolerance of chronic renal failure J Clin Invest 75 3 1985 1037 1044 (Pubitemid 15115274)
-
(1985)
Journal of Clinical Investigation
, vol.75
, Issue.3
, pp. 1037-1044
-
-
Akmal, M.1
Massry, S.G.2
Goldstein, D.A.3
-
3
-
-
0026523822
-
Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients
-
R.H. Mak Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients Kidney Int 41 4 1992 1049 1054
-
(1992)
Kidney Int
, vol.41
, Issue.4
, pp. 1049-1054
-
-
Mak, R.H.1
-
4
-
-
0030665213
-
Carbohydrate and insulin metabolism in renal failure
-
A. Alvestrand Carbohydrate and insulin metabolism in renal failure Kidney Int Suppl 36 1997 S48 S52
-
(1997)
Kidney Int Suppl
, vol.36
-
-
Alvestrand, A.1
-
5
-
-
12744279326
-
Redox paradox: Insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets
-
B.J. Goldstein, K. Mahadev, and X. Wu Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets Diabetes 54 2 2005 311 321
-
(2005)
Diabetes
, vol.54
, Issue.2
, pp. 311-321
-
-
Goldstein, B.J.1
Mahadev, K.2
Wu, X.3
-
6
-
-
79953253731
-
Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease
-
G.Y. Chang, A.S. Park, and K. Susztak Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease Kidney Int 79 8 2011 802 804
-
(2011)
Kidney Int
, vol.79
, Issue.8
, pp. 802-804
-
-
Chang, G.Y.1
Park, A.S.2
Susztak, K.3
-
8
-
-
0019984476
-
Insulin resistance in uremia mediated by postbinding defects
-
D. Smith, and R.A. DeFronzo Insulin resistance in uremia mediated by postbinding defects Kidney Int 22 1 1982 54 62 (Pubitemid 12091218)
-
(1982)
Kidney International
, vol.22
, Issue.1
, pp. 54-62
-
-
Smith, D.1
DeFronzo, R.A.2
-
9
-
-
0026792995
-
Glucose homeostasis and the kidney
-
H.J. Adrogue Glucose homeostasis and the kidney Kidney Int 42 5 1992 1266 1282
-
(1992)
Kidney Int
, vol.42
, Issue.5
, pp. 1266-1282
-
-
Adrogue, H.J.1
-
10
-
-
0025976578
-
Enhanced insulin sensitivity in extrarenal potassium handling in uremic rats
-
I.A. Goecke, S. Bonilla, E.T. Marusic, and M. Alvo Enhanced insulin sensitivity in extrarenal potassium handling in uremic rats Kidney Int 39 1 1991 39 43
-
(1991)
Kidney Int
, vol.39
, Issue.1
, pp. 39-43
-
-
Goecke, I.A.1
Bonilla, S.2
Marusic, E.T.3
Alvo, M.4
-
11
-
-
0018140320
-
Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin
-
R.A. DeFronzo, J.D. Tobin, J.W. Rowe, and R. Andres Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin J Clin Invest 62 2 1978 425 435 (Pubitemid 8393313)
-
(1978)
Journal of Clinical Investigation
, vol.62
, Issue.2
, pp. 425-435
-
-
DeFronzo, R.A.1
Tobin, J.D.2
Rowe, J.W.3
Andres, R.4
-
12
-
-
0022384705
-
Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects
-
O. Schmitz Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects Diabetes 34 11 1985 1152 1159 (Pubitemid 16218520)
-
(1985)
Diabetes
, vol.34
, Issue.11
, pp. 1152-1159
-
-
Schmitz, O.1
-
13
-
-
54049130793
-
Review article: The role of adipose tissue in uraemia-related insulin resistance
-
B. Manolescu, I. Stoian, V. Atanasiu, C. Busu, and O. Lupescu Review article: the role of adipose tissue in uraemia-related insulin resistance Nephrology (Carlton) 13 7 2008 622 628
-
(2008)
Nephrology (Carlton)
, vol.13
, Issue.7
, pp. 622-628
-
-
Manolescu, B.1
Stoian, I.2
Atanasiu, V.3
Busu, C.4
Lupescu, O.5
-
14
-
-
67651097807
-
Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan
-
L.L. Guo, Y. Pan, and H.M. Jin Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan Nephrol Dial Transplant 24 6 2009 1876 1883
-
(2009)
Nephrol Dial Transplant
, vol.24
, Issue.6
, pp. 1876-1883
-
-
Guo, L.L.1
Pan, Y.2
Jin, H.M.3
-
15
-
-
37149054939
-
Inflammation and Insulin Resistance in Uremia
-
DOI 10.1053/j.jrn.2007.10.015, PII S1051227607002336
-
M. Zanetti, R. Barazzoni, and G. Guarnieri Inflammation and insulin resistance in uremia J Ren Nutr 18 1 2008 70 75 (Pubitemid 350258685)
-
(2008)
Journal of Renal Nutrition
, vol.18
, Issue.1
, pp. 70-75
-
-
Zanetti, M.1
Barazzoni, R.2
Guarnieri, G.3
-
16
-
-
69249171375
-
Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients
-
E. Khedr, M. El-Sharkawy, and S. Abdulwahab et al. Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients Hemodial Int 13 3 2009 340 346
-
(2009)
Hemodial Int
, vol.13
, Issue.3
, pp. 340-346
-
-
Khedr, E.1
El-Sharkawy, M.2
Abdulwahab, S.3
-
17
-
-
77955249418
-
Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease
-
E.D. Siew, and T.A. Ikizler Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease Semin Dial 23 4 2010 378 382
-
(2010)
Semin Dial
, vol.23
, Issue.4
, pp. 378-382
-
-
Siew, E.D.1
Ikizler, T.A.2
-
18
-
-
33845804760
-
Effects of Glucose Homeostasis on Protein Metabolism in Patients With Advanced Chronic Kidney Disease
-
DOI 10.1053/j.jrn.2006.10.004, PII S1051227606002305, Proceedings from the XIII International Congress on Nutrition and Metabolism in Renal Disease
-
T.A. Ikizler Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease J Ren Nutr 17 1 2007 13 16 (Pubitemid 46014450)
-
(2007)
Journal of Renal Nutrition
, vol.17
, Issue.1
, pp. 13-16
-
-
Ikizler, T.A.1
-
19
-
-
0033968126
-
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
-
K. Cusi, K. Maezono, and A. Osman et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle J Clin Invest 105 3 2000 311 320 (Pubitemid 30094451)
-
(2000)
Journal of Clinical Investigation
, vol.105
, Issue.3
, pp. 311-320
-
-
Cusi, K.1
Maezono, K.2
Osman, A.3
Pendergrass, M.4
Patti, M.E.5
Pratipanawatr, T.6
DeFronzo, R.A.7
Kahn, C.R.8
Mandarino, L.J.9
-
20
-
-
33846185124
-
Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients
-
DOI 10.1038/sj.ki.5001984, PII 5001984
-
E.D. Siew, L.B. Pupim, K.M. Majchrzak, A. Shintani, P.J. Flakoll, and T.A. Ikizler Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients Kidney Int 71 2 2007 146 152 (Pubitemid 46094688)
-
(2007)
Kidney International
, vol.71
, Issue.2
, pp. 146-152
-
-
Siew, E.D.1
Pupim, L.B.2
Majchrzak, K.M.3
Shintani, A.4
Flakoll, P.J.5
Ikizler, T.A.6
-
22
-
-
0031818196
-
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
-
DOI 10.1046/j.1523-1755.1998.00898.x
-
D. Fliser, G. Pacini, and R. Engelleiter et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease Kidney Int 53 5 1998 1343 1347 (Pubitemid 28316896)
-
(1998)
Kidney International
, vol.53
, Issue.5
, pp. 1343-1347
-
-
Fliser, D.1
Pacini, G.2
Engelleiter, R.3
Kautzky-Willer, A.4
Prager, R.5
Franek, E.6
Ritz, E.7
-
23
-
-
79953241079
-
Glomerular-specific protein kinase C-beta-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity
-
A. Mima, Y. Ohshiro, and M. Kitada et al. Glomerular-specific protein kinase C-beta-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity Kidney Int 79 8 2011 883 896
-
(2011)
Kidney Int
, vol.79
, Issue.8
, pp. 883-896
-
-
Mima, A.1
Ohshiro, Y.2
Kitada, M.3
-
25
-
-
79952221451
-
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
-
J.F. List, and J.M. Whaley Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans Kidney Int Suppl 120 2011 S20 S27
-
(2011)
Kidney Int Suppl
, vol.120
-
-
List, J.F.1
Whaley, J.M.2
-
26
-
-
79952404360
-
SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function
-
M.J. Jurczak, H.Y. Lee, and A.L. Birkenfeld et al. SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function Diabetes 60 3 2011 890 898
-
(2011)
Diabetes
, vol.60
, Issue.3
, pp. 890-898
-
-
Jurczak, M.J.1
Lee, H.Y.2
Birkenfeld, A.L.3
-
27
-
-
77956656798
-
The kidneys as an emerging target for the treatment of diabetes mellitus: What we know, thought we knew and hope to gain
-
M.H. Ahmed The kidneys as an emerging target for the treatment of diabetes mellitus: what we know, thought we knew and hope to gain Int J Diabetes Mellitus 2 2 2010 125 126
-
(2010)
Int J Diabetes Mellitus
, vol.2
, Issue.2
, pp. 125-126
-
-
Ahmed, M.H.1
-
28
-
-
84886829422
-
Canagliflozin approved for type 2 diabetes
-
K. Traynor Canagliflozin approved for type 2 diabetes Am J Health Syst Pharm 70 10 2013 834
-
(2013)
Am J Health Syst Pharm
, vol.70
, Issue.10
, pp. 834
-
-
Traynor, K.1
-
29
-
-
84865479822
-
Why do SGLT2 inhibitors inhibit only 30-50% of renal glucose reabsorption in humans?
-
J.J. Liu, T. Lee, and R.A. Defronzo Why do SGLT2 inhibitors inhibit only 30-50% of renal glucose reabsorption in humans? Diabetes 61 9 2012 2199 2204
-
(2012)
Diabetes
, vol.61
, Issue.9
, pp. 2199-2204
-
-
Liu, J.J.1
Lee, T.2
Defronzo, R.A.3
-
30
-
-
84885171560
-
The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus
-
S. Riser Taylor, and K.B. Harris The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus Pharmacotherapy 33 9 2013 984 999
-
(2013)
Pharmacotherapy
, vol.33
, Issue.9
, pp. 984-999
-
-
Riser Taylor, S.1
Harris, K.B.2
-
31
-
-
84866268783
-
Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
S.E. Inzucchi, R.M. Bergenstal, and J.B. Buse et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 35 6 2012 1364 1379
-
(2012)
Diabetes Care
, vol.35
, Issue.6
, pp. 1364-1379
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
32
-
-
84857195570
-
Managing diabetes in dialysis patients
-
S.M. O'Toole, S.L. Fan, M.M. Yaqoob, and T.A. Chowdhury Managing diabetes in dialysis patients Postgrad Med J 88 1037 2012 160 166
-
(2012)
Postgrad Med J
, vol.88
, Issue.1037
, pp. 160-166
-
-
O'Toole, S.M.1
Fan, S.L.2
Yaqoob, M.M.3
Chowdhury, T.A.4
-
33
-
-
33845760213
-
KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease
-
National Kidney Foundation
-
National Kidney Foundation KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease Am J Kidney Dis 49 2 suppl 2 2007 S12 S154
-
(2007)
Am J Kidney Dis
, vol.49
, Issue.2 SUPPL. 2
-
-
-
34
-
-
0036482285
-
1c in the Diabetes Control and Complications Trial
-
DOI 10.2337/diacare.25.2.275
-
C.L. Rohlfing, H.M. Wiedmeyer, R.R. Little, J.D. England, A. Tennill, and D.E. Goldstein Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial Diabetes Care 25 2 2002 275 278 (Pubitemid 41079621)
-
(2002)
Diabetes Care
, vol.25
, Issue.2
, pp. 275-278
-
-
Rohlfing, C.L.1
Wiedmeyer, H.-M.2
Little, R.R.3
England, J.D.4
Tennill, A.5
Goldstein, D.E.6
-
35
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
I.M. Stratton, A.I. Adler, and H.A. Neil et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 7258 2000 405 412 (Pubitemid 30609442)
-
(2000)
British Medical Journal
, vol.321
, Issue.7258
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
Hadden, D.7
Turner, R.C.8
Holman, R.R.9
-
36
-
-
82455174130
-
Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: A population-based cohort study
-
S. Shurraw, B. Hemmelgarn, and M. Lin et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study Arch Intern Med 171 21 2011 1920 1927
-
(2011)
Arch Intern Med
, vol.171
, Issue.21
, pp. 1920-1927
-
-
Shurraw, S.1
Hemmelgarn, B.2
Lin, M.3
-
37
-
-
79957824748
-
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy
-
J.M. Lachin, G. Viberti, and B. Zinman et al. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy Clin J Am Soc Nephrol 6 5 2011 1032 1040
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.5
, pp. 1032-1040
-
-
Lachin, J.M.1
Viberti, G.2
Zinman, B.3
-
39
-
-
48149095259
-
Translating the A1C assay into estimated average glucose values
-
D.M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, and R.J. Heine Translating the A1C assay into estimated average glucose values Diabetes Care 31 8 2008 1473 1478
-
(2008)
Diabetes Care
, vol.31
, Issue.8
, pp. 1473-1478
-
-
Nathan, D.M.1
Kuenen, J.2
Borg, R.3
Zheng, H.4
Schoenfeld, D.5
Heine, R.J.6
-
40
-
-
79952599949
-
Reexamining metrics for glucose control
-
K.B. Rubinow, and I.B. Hirsch Reexamining metrics for glucose control JAMA 305 11 2011 1132 1133
-
(2011)
JAMA
, vol.305
, Issue.11
, pp. 1132-1133
-
-
Rubinow, K.B.1
Hirsch, I.B.2
-
41
-
-
3142662783
-
Time to move beyond glycosylated haemoglobin
-
DOI 10.1111/j.1464-5491.2004.01318.x
-
R.I. Holt, and I. Gallen Time to move beyond glycosylated haemoglobin Diabet Med 21 7 2004 655 656 (Pubitemid 38916207)
-
(2004)
Diabetic Medicine
, vol.21
, Issue.7
, pp. 655-656
-
-
Holt, R.I.G.1
Gallent, I.2
-
43
-
-
60149110364
-
-
US Renal Data System National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
-
US Renal Data System USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2008 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
-
(2008)
USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States
-
-
-
44
-
-
84871310537
-
US Renal Data System 2012 annual data report
-
e1-e476
-
A.J. Collins, R.N. Foley, and C. Herzog et al. US Renal Data System 2012 annual data report Am J Kidney Dis 61 1 suppl 1 2013 A7 e1-e476
-
(2013)
Am J Kidney Dis
, vol.61
, Issue.1 SUPPL. 1
, pp. 7
-
-
Collins, A.J.1
Foley, R.N.2
Herzog, C.3
-
45
-
-
33749534536
-
Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival
-
DOI 10.1038/sj.ki.5001789, PII 5001789
-
M.E. Williams, E. Lacson Jr., M. Teng, N. Ofsthun, and J.M. Lazarus Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival Kidney Int 70 8 2006 1503 1509 (Pubitemid 44527322)
-
(2006)
Kidney International
, vol.70
, Issue.8
, pp. 1503-1509
-
-
Williams, M.E.1
Lacson Jr., E.2
Teng, M.3
Ofsthun, N.4
Lazarus, J.M.5
-
46
-
-
4544315738
-
Red blood cell survival in chronic renal failure
-
DOI 10.1053/j.ajkd.2004.06.018, PII S0272638604009515
-
J. Ly, R. Marticorena, and S. Donnelly Red blood cell survival in chronic renal failure Am J Kidney Dis 44 4 2004 715 719 (Pubitemid 39237616)
-
(2004)
American Journal of Kidney Diseases
, vol.44
, Issue.4
, pp. 715-719
-
-
Ly, J.1
Marticorena, R.2
Donnelly, S.3
-
47
-
-
0036231304
-
Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure?
-
R.R. Little, A.L. Tennill, and C. Rohlfing et al. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem 48 5 2002 784 786 (Pubitemid 34439117)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.5
, pp. 784-786
-
-
Little, R.R.1
Tennill, A.L.2
Rohlfing, C.3
Wiedmeyer, H.-M.4
Khanna, R.5
Goel, S.6
Agrawal, A.7
Madsen, R.8
Goldstein, D.E.9
-
48
-
-
64849098665
-
Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis
-
J.N. Brown, D.W. Kemp, and K.R. Brice Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis Pharmacotherapy 29 4 2009 468 472
-
(2009)
Pharmacotherapy
, vol.29
, Issue.4
, pp. 468-472
-
-
Brown, J.N.1
Kemp, D.W.2
Brice, K.R.3
-
49
-
-
42149123415
-
1c levels in diabetic subjects on hemodialysis
-
DOI 10.1038/ki.2008.25, PII KI200825
-
T.P. Peacock, Z.K. Shihabi, and A.J. Bleyer et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis Kidney Int 73 9 2008 1062 1068 (Pubitemid 351543905)
-
(2008)
Kidney International
, vol.73
, Issue.9
, pp. 1062-1068
-
-
Peacock, T.P.1
Shihabi, Z.K.2
Bleyer, A.J.3
Dolbare, E.L.4
Byers, J.R.5
Knovich, M.A.6
Calles-Escandon, J.7
Russell, G.B.8
Freedman, B.I.9
-
50
-
-
77951626611
-
Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4
-
H.S. Chen, T.E. Wu, and H.D. Lin et al. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4 Am J Kidney Dis 55 5 2010 867 874
-
(2010)
Am J Kidney Dis
, vol.55
, Issue.5
, pp. 867-874
-
-
Chen, H.S.1
Wu, T.E.2
Lin, H.D.3
-
51
-
-
69249098196
-
Glycaemic control in type 2 diabetic patients on chronic haemodialysis: Use of a continuous glucose monitoring system
-
J.P. Riveline, J. Teynie, and S. Belmouaz et al. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system Nephrol Dial Transplant 24 9 2009 2866 2871
-
(2009)
Nephrol Dial Transplant
, vol.24
, Issue.9
, pp. 2866-2871
-
-
Riveline, J.P.1
Teynie, J.2
Belmouaz, S.3
-
52
-
-
34247637216
-
A1C and survival in maintenance hemodialysis patients
-
DOI 10.2337/dc06-2127
-
K. Kalantar-Zadeh, J.D. Kopple, and D.L. Regidor et al. A1C and survival in maintenance hemodialysis patients Diabetes Care 30 5 2007 1049 1055 (Pubitemid 46684623)
-
(2007)
Diabetes Care
, vol.30
, Issue.5
, pp. 1049-1055
-
-
Kalantar-Zadeh, K.1
Kopple, J.D.2
Regidor, D.L.3
Jing, J.4
Shinaberger, C.S.5
Aronovitz, J.6
McAllister, C.J.7
Whellan, D.8
Sharma, K.9
-
53
-
-
77957315885
-
Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: Comparative results of traditional and time-dependent Cox model analyses
-
M.E. Williams, E. Lacson Jr., W. Wang, J.M. Lazarus, and R. Hakim Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses Clin J Am Soc Nephrol 5 9 2010 1595 1601
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.9
, pp. 1595-1601
-
-
Williams, M.E.1
Lacson, Jr.E.2
Wang, W.3
Lazarus, J.M.4
Hakim, R.5
-
54
-
-
77957306703
-
1c in hemodialysis patients: Should one size fit all?
-
1c in hemodialysis patients: should one size fit all? Clin J Am Soc Nephrol 5 9 2010 1539 1541
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.9
, pp. 1539-1541
-
-
Ix, J.H.1
-
55
-
-
84869857901
-
Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
-
S.P. Ramirez, K.P. McCullough, and J.R. Thumma et al. Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Diabetes Care 35 12 2012 2527 2532
-
(2012)
Diabetes Care
, vol.35
, Issue.12
, pp. 2527-2532
-
-
Ramirez, S.P.1
McCullough, K.P.2
Thumma, J.R.3
-
56
-
-
73349126712
-
Glycemic control and cardiovascular events in diabetic hemodialysis patients
-
C. Drechsler, V. Krane, E. Ritz, W. Marz, and C. Wanner Glycemic control and cardiovascular events in diabetic hemodialysis patients Circulation 120 24 2009 2421 2428
-
(2009)
Circulation
, vol.120
, Issue.24
, pp. 2421-2428
-
-
Drechsler, C.1
Krane, V.2
Ritz, E.3
Marz, W.4
Wanner, C.5
-
57
-
-
0037373850
-
Assessing glycemic control in patients with diabetes and end-stage renal failure
-
DOI 10.1053/ajkd.2003.50114
-
A. Ansari, S. Thomas, and D. Goldsmith Assessing glycemic control in patients with diabetes and end-stage renal failure Am J Kidney Dis 41 3 2003 523 531 (Pubitemid 36278368)
-
(2003)
American Journal of Kidney Diseases
, vol.41
, Issue.3
, pp. 523-531
-
-
Ansari, A.1
Thomas, S.2
Goldsmith, D.3
-
58
-
-
77955156159
-
Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients
-
N. Mittman, B. Desiraju, and I. Fazil et al. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients Kidney Int Suppl 117 2010 S41 S45
-
(2010)
Kidney Int Suppl
, vol.117
-
-
Mittman, N.1
Desiraju, B.2
Fazil, I.3
-
60
-
-
50249186315
-
Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes?
-
M. Abe, and K. Matsumoto Glycated hemoglobin or glycated albumin for assessment of glycemic control in hemodialysis patients with diabetes? Nat Clin Pract Nephrol 4 9 2008 482 483
-
(2008)
Nat Clin Pract Nephrol
, vol.4
, Issue.9
, pp. 482-483
-
-
Abe, M.1
Matsumoto, K.2
-
61
-
-
33947243803
-
Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection
-
DOI 10.1681/ASN.2006070772
-
M. Inaba, S. Okuno, and Y. Kumeda et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection J Am Soc Nephrol 18 3 2007 896 903 (Pubitemid 46434506)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.3
, pp. 896-903
-
-
Inaba, M.1
Okuno, S.2
Kumeda, Y.3
Yamada, S.4
Imanishi, Y.5
Tabata, T.6
Okamura, M.7
Okada, S.8
Yamakawa, T.9
Ishimura, E.10
Nishizawa, Y.11
-
62
-
-
79960311683
-
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients
-
B.I. Freedman, L. Andries, and Z.K. Shihabi et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients Clin J Am Soc Nephrol 6 7 2011 1635 1643
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.7
, pp. 1635-1643
-
-
Freedman, B.I.1
Andries, L.2
Shihabi, Z.K.3
-
63
-
-
84859095662
-
Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction
-
W.J. Kim, C.Y. Park, and K.B. Lee et al. Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction Diabetes Care 35 2 2012 281 286
-
(2012)
Diabetes Care
, vol.35
, Issue.2
, pp. 281-286
-
-
Kim, W.J.1
Park, C.Y.2
Lee, K.B.3
-
64
-
-
58149523217
-
Relationship between dialysis modality and mortality
-
S.P. McDonald, M.R. Marshall, D.W. Johnson, and K.R. Polkinghorne Relationship between dialysis modality and mortality J Am Soc Nephrol 20 1 2009 155 163
-
(2009)
J Am Soc Nephrol
, vol.20
, Issue.1
, pp. 155-163
-
-
McDonald, S.P.1
Marshall, M.R.2
Johnson, D.W.3
Polkinghorne, K.R.4
-
65
-
-
79251591619
-
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease
-
R. Mehrotra, Y.W. Chiu, K. Kalantar-Zadeh, J. Bargman, and E. Vonesh Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease Arch Intern Med 171 2 2011 110 118
-
(2011)
Arch Intern Med
, vol.171
, Issue.2
, pp. 110-118
-
-
Mehrotra, R.1
Chiu, Y.W.2
Kalantar-Zadeh, K.3
Bargman, J.4
Vonesh, E.5
-
66
-
-
77949880842
-
Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
-
E.D. Weinhandl, R.N. Foley, D.T. Gilbertson, T.J. Arneson, J.J. Snyder, and A.J. Collins Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients J Am Soc Nephrol 21 3 2010 499 506
-
(2010)
J Am Soc Nephrol
, vol.21
, Issue.3
, pp. 499-506
-
-
Weinhandl, E.D.1
Foley, R.N.2
Gilbertson, D.T.3
Arneson, T.J.4
Snyder, J.J.5
Collins, A.J.6
-
67
-
-
0346881199
-
Renal replacement therapy in patients with diabetes and end-stage renal disease
-
F. Locatelli, P. Pozzoni, and L. Del Vecchio Renal replacement therapy in patients with diabetes and end-stage renal disease J Am Soc Nephrol 15 suppl 1 2004 S25 S29
-
(2004)
J Am Soc Nephrol
, vol.15
, Issue.SUPPL. 1
-
-
Locatelli, F.1
Pozzoni, P.2
Del Vecchio, L.3
-
68
-
-
77950937491
-
Biocompatible peritoneal dialysis solutions: Do we have one?
-
K. Chaudhary, and R. Khanna Biocompatible peritoneal dialysis solutions: do we have one? Clin J Am Soc Nephrol 5 4 2010 723 732
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.4
, pp. 723-732
-
-
Chaudhary, K.1
Khanna, R.2
-
69
-
-
0035656524
-
Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration
-
E. Quellhorst Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration J Am Soc Nephrol 13 suppl 1 2002 S92 S96
-
(2002)
J Am Soc Nephrol
, vol.13
, Issue.SUPPL. 1
-
-
Quellhorst, E.1
-
70
-
-
0141797504
-
Lesson of the week: Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid
-
S.G. Riley, J. Chess, K.L. Donovan, and J.D. Williams Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid BMJ 327 7415 2003 608 609 (Pubitemid 37115116)
-
(2003)
British Medical Journal
, vol.327
, Issue.7415
, pp. 608-609
-
-
Riley, S.G.1
Chess, J.2
Donovan, K.L.3
Williams, J.D.4
-
71
-
-
84855185039
-
Standards of medical care in diabetes - 2012
-
American Diabetes Association
-
American Diabetes Association Standards of medical care in diabetes - 2012 Diabetes Care 35 suppl 1 2012 S11 S63
-
(2012)
Diabetes Care
, vol.35
, Issue.SUPPL. 1
-
-
-
72
-
-
40049106685
-
Hypoglycaemia in Type 2 diabetes
-
DOI 10.1111/j.1464-5491.2007.02341.x
-
S.A. Amiel, T. Dixon, R. Mann, and K. Jameson Hypoglycaemia in type 2 diabetes Diabet Med 25 3 2008 245 254 (Pubitemid 351322690)
-
(2008)
Diabetic Medicine
, vol.25
, Issue.3
, pp. 245-254
-
-
Amiel, S.A.1
Dixon, T.2
Mann, R.3
Jameson, K.4
-
73
-
-
79952207468
-
Frequent hypoglycemia among elderly patients with poor glycemic control
-
M.N. Munshi, A.R. Segal, and E. Suhl et al. Frequent hypoglycemia among elderly patients with poor glycemic control Arch Intern Med 171 4 2011 362 364
-
(2011)
Arch Intern Med
, vol.171
, Issue.4
, pp. 362-364
-
-
Munshi, M.N.1
Segal, A.R.2
Suhl, E.3
-
74
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
DOI 10.1056/NEJMoa0802743
-
H.C. Gerstein, M.E. Miller, and R.P. Byington et al. Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 24 2008 2545 2559 (Pubitemid 351831356)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2545-2559
-
-
Friedewald, W.T.1
Buse, J.B.2
Bigger, J.T.3
Byington, R.P.4
Cushman, W.C.5
Gerstein, H.C.6
Ginsberg, H.N.7
Goff Jr., D.C.8
Grimm Jr., R.H.9
Ismail-Beigi, F.10
Probstfield, J.L.11
Simons-Morton, D.G.12
-
75
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa0802987
-
A. Patel, S. MacMahon, and J. Chalmers et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 24 2008 2560 2572 (Pubitemid 351831357)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Billot, L.5
Woodward, M.6
Marre, M.7
Cooper, M.8
Glasziou, P.9
Grobbee, D.10
Hamet, P.11
Harrap, S.12
Heller, S.13
Liu, L.14
Mancia, G.15
Mogensen, C.E.16
Pan, C.17
Poulter, N.18
Rodgers, A.19
Williams, B.20
Bompoint, S.21
De Galan, B.E.22
Joshi, R.23
Travert, F.24
more..
-
76
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
W. Duckworth, C. Abraira, and T. Moritz et al. Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2 2009 129 139
-
(2009)
N Engl J Med
, vol.360
, Issue.2
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
-
77
-
-
0008014591
-
Carbohydrate metabolism in end-stage renal disease
-
S.K. Mujais, and G. Fadda Carbohydrate metabolism in end-stage renal disease Semin Dial 2 1989 46 53
-
(1989)
Semin Dial
, vol.2
, pp. 46-53
-
-
Mujais, S.K.1
Fadda, G.2
-
78
-
-
0034055364
-
Hypoglycemia in patients with renal failure
-
DOI 10.1081/JDI-100100866
-
Y.S. Haviv, M. Sharkia, and R. Safadi Hypoglycemia in patients with renal failure Ren Fail 22 2 2000 219 223 (Pubitemid 30243986)
-
(2000)
Renal Failure
, vol.22
, Issue.2
, pp. 219-223
-
-
Haviv, Y.S.1
Sharkia, M.2
Safadi, R.3
-
79
-
-
63349083389
-
Hypoglycemia in diabetic patients undergoing chronic hemodialysis
-
C.Y. Sun, C.C. Lee, and M.S. Wu Hypoglycemia in diabetic patients undergoing chronic hemodialysis Ther Apher Dial 13 2 2009 95 102
-
(2009)
Ther Apher Dial
, vol.13
, Issue.2
, pp. 95-102
-
-
Sun, C.Y.1
Lee, C.C.2
Wu, M.S.3
-
80
-
-
77957318240
-
High glucose variability increases risk of all-cause and hypoglycemia-related hospitalization in diabetic chronic hemodialysis patients [abstract TH-PO349]
-
M.E. Williams, E. Lacson Jr., and W. Wang High glucose variability increases risk of all-cause and hypoglycemia-related hospitalization in diabetic chronic hemodialysis patients [abstract TH-PO349] J Am Soc Nephrol 20 2009 193A
-
(2009)
J Am Soc Nephrol
, vol.20
-
-
Williams, M.E.1
Lacson, Jr.E.2
Wang, W.3
-
81
-
-
49649114691
-
Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia
-
S. Vallurupalli, G. Huesmann, J. Gregory, and M.G. Jakoby Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia Diabet Med 25 7 2008 856 859
-
(2008)
Diabet Med
, vol.25
, Issue.7
, pp. 856-859
-
-
Vallurupalli, S.1
Huesmann, G.2
Gregory, J.3
Jakoby, M.G.4
-
82
-
-
79551673658
-
Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus
-
J.H. O'Keefe, M. Abuannadi, C.J. Lavie, and D.S. Bell Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus Mayo Clin Proc 86 2 2011 128 138
-
(2011)
Mayo Clin Proc
, vol.86
, Issue.2
, pp. 128-138
-
-
O'Keefe, J.H.1
Abuannadi, M.2
Lavie, C.J.3
Bell, D.S.4
-
83
-
-
84856751751
-
1c levels with vascular complications and death in patients with type 2 diabetes: Evidence of glycaemic thresholds
-
1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds Diabetologia 55 3 2012 636 643
-
(2012)
Diabetologia
, vol.55
, Issue.3
, pp. 636-643
-
-
Zoungas, S.1
Chalmers, J.2
Ninomiya, T.3
-
84
-
-
0035349026
-
Impact of Diabetic Nephropathy on Pharmacodynamic and Pharmacokinetic Properties of Insulin in Type 1 Diabetic Patients
-
K. Rave, T. Heise, A. Pfutzner, L. Heinemann, and P.T. Sawicki Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients Diabetes Care 24 5 2001 886 890 (Pubitemid 33636064)
-
(2001)
Diabetes Care
, vol.24
, Issue.5
, pp. 886-890
-
-
Rave, K.1
Heise, T.2
Pfutzner, A.3
Heinemann, L.4
Sawicki, P.T.5
-
85
-
-
84866673865
-
A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency
-
D. Baldwin, J. Zander, and C. Munoz et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency Diabetes Care 35 10 2012 1970 1974
-
(2012)
Diabetes Care
, vol.35
, Issue.10
, pp. 1970-1974
-
-
Baldwin, D.1
Zander, J.2
Munoz, C.3
-
86
-
-
77958160895
-
Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis
-
E. Sobngwi, S. Enoru, and G. Ashuntantang et al. Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis Diabetes Care 33 7 2010 1409 1412
-
(2010)
Diabetes Care
, vol.33
, Issue.7
, pp. 1409-1412
-
-
Sobngwi, E.1
Enoru, S.2
Ashuntantang, G.3
-
87
-
-
0032792964
-
Pharmacokinetics and pharmacodynamics of insulin Lispro compared with regular insulin in haemodialysis patients with diabetes mellitus
-
U. Aisenpreis, A. Pfutzner, M. Giehl, F. Keller, and P.M. Jehle Pharmacokinetics and pharmacodynamics of insulin lispro compared with regular insulin in haemodialysis patients with diabetes mellitus Nephrol Dial Transplant 14 suppl 4 1999 5 6 (Pubitemid 29358840)
-
(1999)
Nephrology Dialysis Transplantation
, vol.14
, Issue.SUPPL. 4
, pp. 5-6
-
-
Aisenpreis, U.1
Pfutzner, A.2
Giehl, M.3
Keller, F.4
Jehle, P.M.5
-
88
-
-
0141927100
-
Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus
-
D. Czock, U. Aisenpreis, F.M. Rasche, and P.M. Jehle Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus Int J Clin Pharmacol Ther 41 10 2003 492 497 (Pubitemid 37258869)
-
(2003)
International Journal of Clinical Pharmacology and Therapeutics
, vol.41
, Issue.10
, pp. 492-497
-
-
Czock, D.1
Aisenpreis, U.2
Rasche, F.M.3
Jehle, P.M.4
-
89
-
-
27444437085
-
Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment
-
DOI 10.1111/j.1365-2125.2005.02476.x
-
G. Holmes, L. Galitz, P. Hu, and W. Lyness Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment Br J Clin Pharmacol 60 5 2005 469 476 (Pubitemid 41532446)
-
(2005)
British Journal of Clinical Pharmacology
, vol.60
, Issue.5
, pp. 469-476
-
-
Holmes, G.1
Galitz, L.2
Hu, P.3
Lyness, W.4
-
90
-
-
60449089649
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
D.M. Nathan, J.B. Buse, and M.B. Davidson et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 1 2009 193 203
-
(2009)
Diabetes Care
, vol.32
, Issue.1
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
91
-
-
75549091263
-
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control
-
H.W. Rodbard, P.S. Jellinger, and J.A. Davidson et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endocr Pract 15 6 2009 540 559
-
(2009)
Endocr Pract
, vol.15
, Issue.6
, pp. 540-559
-
-
Rodbard, H.W.1
Jellinger, P.S.2
Davidson, J.A.3
-
92
-
-
84856740961
-
Oral pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians
-
A. Qaseem, L.L. Humphrey, D.E. Sweet, M. Starkey, and P. Shekelle Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians Ann Intern Med 156 3 2012 218 231
-
(2012)
Ann Intern Med
, vol.156
, Issue.3
, pp. 218-231
-
-
Qaseem, A.1
Humphrey, L.L.2
Sweet, D.E.3
Starkey, M.4
Shekelle, P.5
-
93
-
-
84855286477
-
Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: A systematic review
-
W.L. Bennett, O.A. Odelola, and L.M. Wilson et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review Ann Intern Med 156 1, pt 1 2012 27 36
-
(2012)
Ann Intern Med
, vol.156
, Issue.1 PART 1
, pp. 27-36
-
-
Bennett, W.L.1
Odelola, O.A.2
Wilson, L.M.3
-
94
-
-
0038729523
-
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia
-
A. Holstein, A. Plaschke, C. Hammer, and E.H. Egberts Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia Eur J Clin Pharmacol 59 2 2003 91 97 (Pubitemid 36793719)
-
(2003)
European Journal of Clinical Pharmacology
, vol.59
, Issue.2
, pp. 91-97
-
-
Holstein, A.1
Plaschke, A.2
Hammer, C.3
Egberts, E.-H.4
-
95
-
-
84857192367
-
Characteristics of patients with sulphonurea-induced hypoglycemia
-
Y.D. Schejter, E. Turvall, and Z. Ackerman Characteristics of patients with sulphonurea-induced hypoglycemia J Am Med Dir Assoc 13 3 2012 234 238
-
(2012)
J Am Med Dir Assoc
, vol.13
, Issue.3
, pp. 234-238
-
-
Schejter, Y.D.1
Turvall, E.2
Ackerman, Z.3
-
96
-
-
0029857682
-
Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment
-
DOI 10.1007/s001250050624
-
B. Rosenkranz, V. Profozic, Z. Metelko, V. Mrzljak, C. Lange, and V. Malerczyk Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment Diabetologia 39 12 1996 1617 1624 (Pubitemid 26397377)
-
(1996)
Diabetologia
, vol.39
, Issue.12
, pp. 1617-1624
-
-
Rosenkranz, B.1
Profozic, V.2
Metelko, Z.3
Mrzljak, V.4
Lange, C.5
Malerczyk, V.6
-
97
-
-
37349117398
-
Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?
-
DOI 10.1111/j.1463-1326.2006.00657.x
-
S. Runge, J. Mayerle, and C. Warnke et al. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metab 10 1 2008 91 93 (Pubitemid 350302435)
-
(2008)
Diabetes, Obesity and Metabolism
, vol.10
, Issue.1
, pp. 91-93
-
-
Runge, S.1
Mayerle, J.2
Warnke, C.3
Robinson, D.4
Roser, M.5
Felix, S.B.6
Friesecke, S.7
-
98
-
-
67651119920
-
Prescribing metformin in type 2 diabetes with a contraindication: Prevalence and outcome
-
J. Pongwecharak, N. Tengmeesri, N. Malanusorn, M. Panthong, and N. Pawangkapin Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome Pharm World Sci 31 4 2009 481 486
-
(2009)
Pharm World Sci
, vol.31
, Issue.4
, pp. 481-486
-
-
Pongwecharak, J.1
Tengmeesri, N.2
Malanusorn, N.3
Panthong, M.4
Pawangkapin, N.5
-
99
-
-
77953634420
-
Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis
-
M. Abe, K. Okada, T. Maruyama, N. Maruyama, M. Soma, and K. Matsumoto Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis Expert Opin Pharmacother 11 10 2010 1611 1620
-
(2010)
Expert Opin Pharmacother
, vol.11
, Issue.10
, pp. 1611-1620
-
-
Abe, M.1
Okada, K.2
Maruyama, T.3
Maruyama, N.4
Soma, M.5
Matsumoto, K.6
-
100
-
-
0344233280
-
Effects of Rosiglitazone Maleate When Added to a Sulfonylurea Regimen in Patients with Type 2 Diabetes Mellitus and Mild to Moderate Renal Impairment: A Post Hoc Analysis
-
DOI 10.1016/S0149-2918(03)80331-4
-
A. Agrawal, M.C. Sautter, and N.P. Jones Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: a post hoc analysis Clin Ther 25 11 2003 2754 2764 (Pubitemid 37510588)
-
(2003)
Clinical Therapeutics
, vol.25
, Issue.11
, pp. 2754-2764
-
-
Agrawal, A.1
Sautter, M.C.2
Jones, N.P.3
-
101
-
-
33846003119
-
Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: Effectiveness and side effects
-
C.K. Chiang, T.I. Ho, and Y.S. Peng et al. Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects Diabetes Care 30 1 2007 3 7
-
(2007)
Diabetes Care
, vol.30
, Issue.1
, pp. 3-7
-
-
Chiang, C.K.1
Ho, T.I.2
Peng, Y.S.3
-
102
-
-
26244453309
-
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): A randomised controlled trial
-
DOI 10.1016/S0140-6736(05)67528-9, PII S0140673605675289
-
J.A. Dormandy, B. Charbonnel, and D.J. Eckland et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 9493 2005 1279 1289 (Pubitemid 41416583)
-
(2005)
Lancet
, vol.366
, Issue.9493
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
Erdmann, E.4
Massi-Benedetti, M.5
Moules, I.K.6
Skene, A.M.7
Tan, M.H.8
Lefebvre, P.J.9
Murray, G.D.10
Standl, E.11
Wilcox, R.G.12
Wilhelmsen, L.13
Betteridge, J.14
Birkeland, K.15
Golay, A.16
Heine, R.J.17
Koranyi, L.18
Laakso, M.19
Mokan, M.20
Norkus, A.21
Pirags, V.22
Podar, T.23
Scheen, A.24
Scherbaum, W.25
Schernthaner, G.26
Schmitz, O.27
Skrha, J.28
Smith, U.29
Taton, J.30
more..
-
103
-
-
38149077162
-
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease
-
C.A. Schneider, E. Ferrannini, R. Defronzo, G. Schernthaner, J. Yates, and E. Erdmann Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease J Am Soc Nephrol 19 1 2008 182 187
-
(2008)
J Am Soc Nephrol
, vol.19
, Issue.1
, pp. 182-187
-
-
Schneider, C.A.1
Ferrannini, E.2
Defronzo, R.3
Schernthaner, G.4
Yates, J.5
Erdmann, E.6
-
104
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 24 2007 2457 2471 (Pubitemid 46919772)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.24
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
105
-
-
65649089128
-
Rosiglitazone is associated with mortality in chronic hemodialysis patients
-
S.P. Ramirez, J.M. Albert, and M.J. Blayney et al. Rosiglitazone is associated with mortality in chronic hemodialysis patients J Am Soc Nephrol 20 5 2009 1094 1101
-
(2009)
J Am Soc Nephrol
, vol.20
, Issue.5
, pp. 1094-1101
-
-
Ramirez, S.P.1
Albert, J.M.2
Blayney, M.J.3
-
106
-
-
79956217900
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study
-
J.D. Lewis, A. Ferrara, and T. Peng et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study Diabetes Care 34 4 2011 916 922
-
(2011)
Diabetes Care
, vol.34
, Issue.4
, pp. 916-922
-
-
Lewis, J.D.1
Ferrara, A.2
Peng, T.3
-
107
-
-
45449105789
-
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
-
DOI 10.1111/j.1463-1326.2008.00914.x
-
J.C. Chan, R. Scott, and J.C. Arjona Ferreira et al. Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency Diabetes Obes Metab 10 7 2008 545 555 (Pubitemid 351850898)
-
(2008)
Diabetes, Obesity and Metabolism
, vol.10
, Issue.7
, pp. 545-555
-
-
Chan, J.C.N.1
Scott, R.2
Arjona Ferreira, J.C.3
Sheng, D.4
Gonzalez, E.5
Davies, M.J.6
Stein, P.P.7
Kaufman, K.D.8
Amatruda, J.M.9
Williams-Herman, D.10
-
108
-
-
80052530183
-
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*)
-
U. Graefe-Mody, C. Friedrich, and A. Port et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*) Diabetes Obes Metab 13 10 2011 939 946
-
(2011)
Diabetes Obes Metab
, vol.13
, Issue.10
, pp. 939-946
-
-
Graefe-Mody, U.1
Friedrich, C.2
Port, A.3
-
109
-
-
80052551137
-
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: A prospective 24-week randomized placebo-controlled trial
-
V. Lukashevich, A. Schweizer, Q. Shao, P.H. Groop, and W. Kothny Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial Diabetes Obes Metab 13 10 2011 947 954
-
(2011)
Diabetes Obes Metab
, vol.13
, Issue.10
, pp. 947-954
-
-
Lukashevich, V.1
Schweizer, A.2
Shao, Q.3
Groop, P.H.4
Kothny, W.5
-
110
-
-
81755181497
-
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: A randomised controlled 52-week efficacy and safety study
-
M. Nowicki, I. Rychlik, and H. Haller et al. Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study Int J Clin Pract 65 12 2011 1230 1239
-
(2011)
Int J Clin Pract
, vol.65
, Issue.12
, pp. 1230-1239
-
-
Nowicki, M.1
Rychlik, I.2
Haller, H.3
-
111
-
-
79955048927
-
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment
-
M. Nowicki, I. Rychlik, H. Haller, M.L. Warren, L. Suchower, and I. Gause-Nilsson Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment Diabetes Obes Metab 13 6 2011 523 532
-
(2011)
Diabetes Obes Metab
, vol.13
, Issue.6
, pp. 523-532
-
-
Nowicki, M.1
Rychlik, I.2
Haller, H.3
Warren, M.L.4
Suchower, L.5
Gause-Nilsson, I.6
-
112
-
-
67649666737
-
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
-
J.B. Buse, J. Rosenstock, and G. Sesti et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) Lancet 374 9683 2009 39 47
-
(2009)
Lancet
, vol.374
, Issue.9683
, pp. 39-47
-
-
Buse, J.B.1
Rosenstock, J.2
Sesti, G.3
-
113
-
-
84872084453
-
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): A randomised, open-label study
-
J.B. Buse, M. Nauck, and T. Forst et al. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study Lancet 381 9861 2013 117 124
-
(2013)
Lancet
, vol.381
, Issue.9861
, pp. 117-124
-
-
Buse, J.B.1
Nauck, M.2
Forst, T.3
-
114
-
-
70849096647
-
Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
-
L.V. Jacobsen, C. Hindsberger, R. Robson, and M. Zdravkovic Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide Br J Clin Pharmacol 68 6 2009 898 905
-
(2009)
Br J Clin Pharmacol
, vol.68
, Issue.6
, pp. 898-905
-
-
Jacobsen, L.V.1
Hindsberger, C.2
Robson, R.3
Zdravkovic, M.4
-
115
-
-
34548034895
-
Effect of renal impairment on the pharmacokinetics of exenatide
-
DOI 10.1111/j.1365-2125.2007.02890.x
-
H. Linnebjerg, P.A. Kothare, and S. Park et al. Effect of renal impairment on the pharmacokinetics of exenatide Br J Clin Pharmacol 64 3 2007 317 327 (Pubitemid 47283860)
-
(2007)
British Journal of Clinical Pharmacology
, vol.64
, Issue.3
, pp. 317-327
-
-
Linnebjerg, H.1
Kothare, P.A.2
Park, S.3
Mace, K.4
Reddy, S.5
Mitchell, M.6
Lins, R.7
-
117
-
-
78349307376
-
Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers
-
A. Lopez-Ruiz, C. del Peso-Gilsanz, and A. Meoro-Aviles et al. Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers Pharm World Sci 32 5 2010 559 561
-
(2010)
Pharm World Sci
, vol.32
, Issue.5
, pp. 559-561
-
-
Lopez-Ruiz, A.1
Del Peso-Gilsanz, C.2
Meoro-Aviles, A.3
-
118
-
-
84862777558
-
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: A retrospective claims analysis
-
M. Pendergrass, C. Fenton, S.M. Haffner, and W. Chen Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis Diabetes Obes Metab 14 7 2012 596 600
-
(2012)
Diabetes Obes Metab
, vol.14
, Issue.7
, pp. 596-600
-
-
Pendergrass, M.1
Fenton, C.2
Haffner, S.M.3
Chen, W.4
-
119
-
-
84876063836
-
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: A population-based matched case-control study
-
S. Singh, H.Y. Chang, T.M. Richards, J.P. Weiner, J.M. Clark, and J.B. Segal Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study JAMA Intern Med 173 7 2013 534 539
-
(2013)
JAMA Intern Med
, vol.173
, Issue.7
, pp. 534-539
-
-
Singh, S.1
Chang, H.Y.2
Richards, T.M.3
Weiner, J.P.4
Clark, J.M.5
Segal, J.B.6
-
120
-
-
79951704452
-
Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: A retrospective observational pharmacy claims analysis
-
R. Garg, W. Chen, and M. Pendergrass Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis Diabetes Care 33 11 2010 2349 2354
-
(2010)
Diabetes Care
, vol.33
, Issue.11
, pp. 2349-2354
-
-
Garg, R.1
Chen, W.2
Pendergrass, M.3
-
121
-
-
67649304917
-
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
-
D.D. Dore, J.D. Seeger, and K. Arnold Chan Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide Curr Med Res Opin 25 4 2009 1019 1027
-
(2009)
Curr Med Res Opin
, vol.25
, Issue.4
, pp. 1019-1027
-
-
Dore, D.D.1
Seeger, J.D.2
Arnold Chan, K.3
-
122
-
-
84860567470
-
Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
-
B. Gier, A.V. Matveyenko, D. Kirakossian, D. Dawson, S.M. Dry, and P.C. Butler Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model Diabetes 61 5 2012 1250 1262
-
(2012)
Diabetes
, vol.61
, Issue.5
, pp. 1250-1262
-
-
Gier, B.1
Matveyenko, A.V.2
Kirakossian, D.3
Dawson, D.4
Dry, S.M.5
Butler, P.C.6
-
123
-
-
77950228684
-
Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
-
L. Bjerre Knudsen, L.W. Madsen, and S. Andersen et al. Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation Endocrinology 151 4 2010 1473 1486
-
(2010)
Endocrinology
, vol.151
, Issue.4
, pp. 1473-1486
-
-
Bjerre Knudsen, L.1
Madsen, L.W.2
Andersen, S.3
-
124
-
-
79952284556
-
GLP-1 and calcitonin concentration in humans: Lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
-
L. Hegedus, A.C. Moses, M. Zdravkovic, T. Le Thi, and G.H. Daniels GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide J Clin Endocrinol Metab 96 3 2011 853 860
-
(2011)
J Clin Endocrinol Metab
, vol.96
, Issue.3
, pp. 853-860
-
-
Hegedus, L.1
Moses, A.C.2
Zdravkovic, M.3
Le Thi, T.4
Daniels, G.H.5
-
125
-
-
0037302079
-
Pharmacokinetics of nateglinide in renally impaired diabetic patients
-
DOI 10.1177/0091270002239825
-
D. Devineni, Y.H. Walter, H.T. Smith, J.S. Lee, P. Prasad, and J.F. McLeod Pharmacokinetics of nateglinide in renally impaired diabetic patients J Clin Pharmacol 43 2 2003 163 170 (Pubitemid 36125943)
-
(2003)
Journal of Clinical Pharmacology
, vol.43
, Issue.2
, pp. 163-170
-
-
Devineni, D.1
Walter, H.Y.2
Harold, T.S.3
Lee, J.S.4
Prasad, P.5
McLeod, J.F.6
-
126
-
-
0042532061
-
Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure
-
T. Inoue, N. Shibahara, and K. Miyagawa et al. Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure Clin Nephrol 60 2 2003 90 95 (Pubitemid 36975183)
-
(2003)
Clinical Nephrology
, vol.60
, Issue.2
, pp. 90-95
-
-
Inoue, T.1
Shibahara, N.2
Miyagawa, K.3
Itahana, R.4
Izumi, M.5
Nakanishi, T.6
Takamitsu, Y.7
-
127
-
-
0027724063
-
Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus
-
J.A. Balfour, and D. McTavish Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus Drugs 46 6 1993 1025 1054 (Pubitemid 24016644)
-
(1993)
Drugs
, vol.46
, Issue.6
, pp. 1025-1054
-
-
Balfour, J.A.1
McTavish, D.2
-
128
-
-
32344433818
-
Hepatotoxicity associated with acarbose therapy
-
S.H. Hsiao, L.H. Liao, P.N. Cheng, and T.J. Wu Hepatotoxicity associated with acarbose therapy Ann Pharmacother 40 1 2006 151 154
-
(2006)
Ann Pharmacother
, vol.40
, Issue.1
, pp. 151-154
-
-
Hsiao, S.H.1
Liao, L.H.2
Cheng, P.N.3
Wu, T.J.4
-
129
-
-
33947120281
-
Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes
-
DOI 10.1016/j.clinthera.2007.01.003, PII S0149291807000173
-
F.J. Zieve, M.F. Kalin, S.L. Schwartz, M.R. Jones, and W.L. Bailey Results of the Glucose-Lowering Effect of WelChol Study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes Clin Ther 29 1 2007 74 83 (Pubitemid 46414026)
-
(2007)
Clinical Therapeutics
, vol.29
, Issue.1
, pp. 74-83
-
-
Zieve, F.J.1
Kalin, M.F.2
Schwartz, S.L.3
Jones, M.R.4
Bailey, W.L.5
-
130
-
-
78049465403
-
Bromocriptine mesylate for glycemic management in type 2 diabetes mellitus
-
J.L. Kerr, E.M. Timpe, and K.A. Petkewicz Bromocriptine mesylate for glycemic management in type 2 diabetes mellitus Ann Pharmacother 44 11 2010 1777 1785
-
(2010)
Ann Pharmacother
, vol.44
, Issue.11
, pp. 1777-1785
-
-
Kerr, J.L.1
Timpe, E.M.2
Petkewicz, K.A.3
-
131
-
-
77958179761
-
Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes
-
J.M. Gaziano, A.H. Cincotta, and C.M. O'Connor et al. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes Diabetes Care 33 7 2010 1503 1508
-
(2010)
Diabetes Care
, vol.33
, Issue.7
, pp. 1503-1508
-
-
Gaziano, J.M.1
Cincotta, A.H.2
O'Connor, C.M.3
-
132
-
-
69549130787
-
Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes
-
M. Riddle, R. Pencek, S. Charenkavanich, K. Lutz, K. Wilhelm, and L. Porter Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes Diabetes Care 32 9 2009 1577 1582
-
(2009)
Diabetes Care
, vol.32
, Issue.9
, pp. 1577-1582
-
-
Riddle, M.1
Pencek, R.2
Charenkavanich, S.3
Lutz, K.4
Wilhelm, K.5
Porter, L.6
-
133
-
-
84862777052
-
Comparative effectiveness of incident oral antidiabetic drugs on kidney function
-
A.M. Hung, C.L. Roumie, and R.A. Greevy et al. Comparative effectiveness of incident oral antidiabetic drugs on kidney function Kidney Int 81 7 2012 698 706
-
(2012)
Kidney Int
, vol.81
, Issue.7
, pp. 698-706
-
-
Hung, A.M.1
Roumie, C.L.2
Greevy, R.A.3
-
134
-
-
52049120372
-
Glycemic control in diabetic CKD patients: Where do we stand?
-
C.P. Kovesdy, K. Sharma, and K. Kalantar-Zadeh Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis 52 2008 766 777
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 766-777
-
-
Kovesdy, C.P.1
Sharma, K.2
Kalantar-Zadeh, K.3
|